Comparison the analgesic effect of Remimazolam and Propofol on general anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008349

Enrollment

Registered

2023-04-11

Start date

2023-06-01

Completion date

Unknown

Last updated

2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : propofol group: Induction of anesthesia with Ce 4mcg/ml of propofol target controlled infusion by intravenous infusion, and adjusting propofol infusion rate to maintain Bispectral index 40-60

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American society of anesthesiologist classification 1-3 patients under elective general anesthesia

Exclusion criteria

Exclusion criteria: 1) refusal of patients 2) Contraindication of propofol or remimazolam 3) impossibility of tetanic stimulation application 4) estimated GFR 40kg/m2

Design outcomes

Primary

Measure	Time frame
comparison of ANI changes in both groups	—

Secondary

Measure	Time frame
comparison of ANI changes in both groups with remifentanil infusion	—

Countries

Korea, Republic of

Contacts

Public ContactJiyeon Park

Kangbuk Samsung Medical Center

blestbelle@naver.com+82-2-2001-1383

Outcome results